Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interhemispheric facilitation is a neurophysiological phenomenon describing the excitatory influence of one hemisphere’s brain region—most often the motor cortex—on its contralateral homolog, mediated by neural projections through the corpus callosum.[1][3][4] This facilitation is measured experimentally using transcranial magnetic or electrical stimulation, particularly by observing the effects of a conditioning stimulus on neural activity or motor evoked potentials. It is important for integrated bimanual movement control and can be modulated by task, context, and underlying neural circuitry. The process coexists with interhemispheric inhibition, with both contributing to fine motor coordination, and may be altered by age, polymorphisms (e.g., BDNF), and pathology such as callosal lesions, stroke, or neurodegenerative diseases.[2][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interhemispheric facilitation.